sinc
porcin
epidem
diarrhea
coronaviru
pedv
caus
signific
damag
global
pork
industri
howev
classic
pedv
vaccin
strain
provid
limit
protect
emerg
strain
studi
success
isol
attenu
pedv
epidem
strain
character
good
cell
adapt
hightit
product
h
post
infect
vero
cell
attenu
viru
induc
high
level
virusspecif
neutral
antibodi
day
immun
piglet
provid
complet
protect
challeng
emerg
viru
strain
day
post
immun
moreov
capabl
activ
dendrit
cell
dc
isol
identifi
higher
express
level
ifnc
record
dc
treatment
h
furthermor
genom
sequenc
phylogenet
analysi
reveal
high
homolog
main
antigen
epitop
pedv
pandem
isol
follow
combin
glycosyl
site
predict
result
distribut
within
spatial
structur
protein
led
conclus
observ
effect
host
immun
respons
compar
possibl
associ
lack
potenti
glycosyl
site
amino
acid
protein
summari
illustr
attenu
viru
repres
promis
vaccin
candid
porcin
epidem
diarrhea
ped
acut
viral
enter
diseas
character
sever
villu
atrophi
vomit
wateri
diarrhea
first
report
uk
recent
new
wave
ped
viru
infect
emerg
worldwid
sinc
end
character
compar
high
mortal
rate
among
suckl
piglet
caus
signific
econom
loss
swine
industri
death
us
swine
popul
variou
approach
util
control
diseas
outbreak
mani
classic
pedv
live
vaccin
includ
japan
korea
strain
without
pathogen
induc
robust
immun
respons
sow
succeed
control
classic
pedv
infect
pig
farm
three
decad
exampl
isol
pig
ped
outbreak
belgium
attenu
vaccin
strain
prepar
via
serial
passag
strain
cell
cultur
strain
wide
use
asian
countri
provid
effect
immunolog
protect
herd
almost
two
decad
howev
tradit
attenu
pedv
vaccin
typic
display
lower
serum
antibodi
titer
emerg
pedv
strain
suggest
classic
pedv
vaccin
strain
may
provid
partial
crossprotect
highli
virul
strain
low
immun
protect
effici
attribut
remark
antigen
variat
structur
protein
major
antigen
site
classic
emerg
pedv
isol
virus
coopt
host
cellular
biosynthet
pathway
modifi
protein
present
surfac
sever
virus
report
util
cellular
glycosyl
pathway
host
cell
invas
immun
evas
includ
influenza
hiv
hepat
west
nile
viru
protein
pedv
one
glycosyl
protein
natur
mani
glycosyl
site
featur
high
mannos
composit
viral
evolut
site
easili
ad
delet
result
potenti
modif
divers
increas
complex
viral
glycoprotein
dc
wide
distribut
beneath
mucos
surfac
dermal
layer
power
antigenpres
cell
within
intestin
mucos
immun
system
dcmediat
modul
immun
respons
highli
depend
matur
statu
dc
encount
exogen
microorgan
therefor
capac
vaccin
stimul
matur
dc
induc
tcell
respons
also
import
criterion
vaccin
evalu
research
evalu
potenti
vaccin
one
pedv
attenu
viru
combin
sequenc
charact
dc
stimul
abil
isol
explor
mechan
account
high
immun
protect
effici
isol
fluorescentlabel
antipig
respect
isotyp
fluorochromematch
control
antibodi
mous
mous
purchas
abcam
china
fitcmhcii
isotyp
control
mous
purchas
lifespan
bioscienc
usa
ebiosci
usa
respect
antipedv
spike
protein
monoclon
antibodi
purchas
median
diagnost
south
korea
vero
cell
atcc
provid
veterinari
medicin
research
centr
da
bei
nong
group
intestin
fecal
sampl
collect
piglet
display
clinic
featur
associ
ped
viru
isol
conduct
accord
previous
describ
protocol
adapt
cell
passag
one
pedv
strain
success
isol
proven
free
pathogen
thu
consid
safe
use
neonat
pig
veterinari
medicin
research
centr
da
bei
nong
group
infect
vero
cell
onestep
growth
curv
strain
confirm
via
rtpcr
tabl
plaqu
assay
indirect
immunofluoresc
assay
ifa
subsequ
infect
base
pedv
strain
sequenc
genbank
primer
see
tabl
design
amplif
genom
end
genom
valid
use
full
race
core
set
primescript
clontech
japan
phylogenet
tree
construct
comput
program
mega
version
util
neighborjoin
method
refer
strain
use
phylogenet
analysi
list
tabl
potenti
nglycan
glycosyl
site
spike
protein
predict
via
netnglyc
server
wwwcbsdtudkservic
netnglyc
spike
protein
crystal
structur
analysi
distribut
predict
glycosyl
site
pedv
crystal
structur
coronaviru
spike
protein
appli
homolog
model
protein
sequenc
use
swissmodel
workspac
base
previous
predict
result
ntermin
glycosyl
site
highlight
amino
acid
sequenc
differenti
glycosyl
site
three
strain
fig
surfac
inform
biosynthet
pathway
gener
nlink
glycosyl
potenti
size
glycan
structur
addit
nglycosyl
site
util
centr
circl
radiu
nm
fig
amino
acid
area
mark
potenti
cover
nglycosyl
site
immun
protect
effici
analysi
strain
design
anim
experi
total
caesarianderiv
colostrumdepriv
piglet
larg
white
chosen
serolog
confirm
neg
pedv
tgev
antibodi
via
indirect
elisa
piglet
randomli
assign
three
group
control
artifici
fed
milk
hous
three
separ
room
three
group
intramuscularli
immun
ml
ml
volum
salin
respect
emulsifi
complet
freund
adjuv
subsequ
immun
sera
sampl
piglet
three
differ
group
collect
immun
explor
whether
piglet
gener
pedv
neutral
antibodi
previous
describ
day
immun
piglet
chosen
assign
group
six
piglet
per
group
piglet
divid
accord
origin
group
group
hous
separ
room
piglet
group
oral
challeng
ml
midml
pedv
fourthgener
tissu
virul
viru
intestin
tissu
virul
pedv
infect
piglet
anim
experi
approv
institut
anim
care
use
committe
nanj
agricultur
univers
nanj
china
follow
guidelin
nation
institut
health
follow
challeng
infect
piglet
examin
clinic
symptom
per
day
addit
fece
piglet
subject
score
fecal
consist
use
follow
criteria
normal
semiliquid
without
form
consist
wateryliquid
content
fecal
score
record
daili
six
day
viral
challeng
prior
inocul
fecal
swab
collect
daili
piglet
brief
viral
rna
extract
supernat
follow
centrifug
fecal
suspens
min
use
magmaxtm
viral
rna
isol
kit
life
technolog
carlsbad
ca
magnet
particl
processor
thermofish
scientif
waltham
ca
use
recommend
protocol
respect
manufactur
primer
probe
design
accord
previous
publish
method
follow
challeng
infect
piglet
examin
daili
symptom
diarrhea
examin
period
two
piglet
pb
treatment
group
develop
diarrhea
day
three
euthan
patholog
examin
dpi
day
postinocul
moreov
two
piglet
treatment
group
piglet
develop
diarrhea
randomli
select
comparison
necropsi
intestin
major
organ
examin
jejunum
sampl
three
sampl
taken
cm
interv
place
paraformaldehyd
dehydr
grade
alcohol
embed
paraffin
directli
cut
lm
section
onto
microscop
slide
four
micron
section
cut
stain
hematoxylin
eosin
h
e
formalinfix
paraffinembed
tissu
prepar
test
via
immunofluoresc
ifa
detect
pedv
antigen
swine
dc
obtain
bone
marrow
piglet
femur
accord
method
optim
laboratori
previous
publish
dc
inocul
multipl
infect
moi
h
co
dc
wash
pb
three
time
remov
unbound
viru
maintain
mainten
medium
supplement
fb
follow
cultur
h
dc
stain
anti
monoclon
antibodi
via
fac
investig
viru
uptak
altern
dc
stain
h
variou
phenotyp
fluoresc
mab
isotyp
investig
via
fac
furthermor
transcript
level
ifnc
determin
via
quantit
rtqpcr
analysi
util
steponeplu
abi
instrument
life
technolog
see
tabl
function
activ
dc
reflect
primari
allogen
mix
lymphocyt
reaction
assay
tcell
separ
mln
allogen
piglet
use
tcell
isol
kit
miltenyi
bergisch
gladbach
germani
label
carboxyfluorescein
succinimidyl
ester
cfse
invitrogen
subsequ
tlymphocyt
cellwel
cocultur
dc
treat
moi
moi
lp
ugmlwel
mockdc
ratio
dc
lymphocyt
cocultur
incub
co
five
day
cultur
cell
prolifer
measur
via
fac
result
express
mean
sd
analysi
varianc
anova
student
test
employ
determin
statist
differ
strain
induc
appar
classic
cytopath
effect
cpe
vero
cell
includ
cell
fusion
two
one
extra
potenti
glycosyl
site
aa
sequenc
shown
ribbon
potenti
cover
region
glycosyl
site
dot
radiu
nm
shown
surfac
site
aa
sequenc
shown
ballsandstick
multinucl
giant
cell
format
h
infect
immunofluoresc
protein
readili
visibl
h
infect
initi
distribut
plasma
membran
follow
distribut
cytoplasm
quick
increas
hpi
fluoresc
intens
proport
viru
inocul
dose
fig
growthkinet
studi
show
replic
rapidli
effici
vero
cell
almost
logarithm
growth
form
h
h
reach
maximum
titer
pfuml
hpi
fig
c
complet
genom
strain
length
nucleotid
nt
exclud
poli
tail
genom
organ
similar
report
pedv
characterist
gene
order
nt
aa
sequenc
ident
differ
region
within
genom
compar
pedv
strain
tabl
nucleotid
sequenc
gene
strain
nt
length
encod
predict
protein
contain
amino
acid
aa
display
aa
ident
refer
isol
similar
isol
tabl
phylogenet
analys
base
nucleotid
aa
reveal
belong
group
iic
also
contain
chines
domest
pandem
cell
adapt
strain
report
sinc
fig
b
howev
analysi
coe
sequenc
select
strain
show
cluster
group
ia
share
sequenc
homolog
strain
isol
worldwid
sinc
pedv
pandem
fig
addit
deduc
aa
sequenc
partial
gene
analysi
show
aa
chang
known
neutral
epitop
aa
mere
two
aa
substitut
neutral
epitop
aa
strain
regardless
locat
phylogenet
tree
fig
b
accessori
gene
locat
structur
gene
e
suggest
cell
marker
pedv
adapt
attenu
hljbi
sdm
share
delet
nt
nt
caus
shift
read
frame
fig
c
accord
predict
result
total
number
potenti
nglycan
glycosyl
site
strain
rang
compar
vaccin
strain
virul
strain
one
posit
three
posit
potenti
glycosyl
site
miss
previous
establish
chang
glycosyl
affect
interact
receptor
caus
viru
becom
either
less
recogniz
host
immun
cell
thu
impact
viral
replic
infect
model
structur
protein
pedv
strain
well
spatial
posit
nglycosyl
site
addit
nglycosyl
site
use
centr
circl
radiu
nm
fig
amino
acid
area
may
cover
nglycosyl
site
mark
almost
locat
aa
sequenc
posit
protein
result
pedvneutr
antibodi
test
reveal
antibodi
neutral
level
strain
immun
group
increas
gradual
begin
day
seven
first
immun
still
maintain
high
level
dpi
neutral
antibodi
titer
serum
sampl
group
immun
pedv
strain
significantli
higher
group
p
p
fig
interv
day
day
subsequ
virul
pedv
challeng
diarrhea
appear
day
pb
pretreat
group
peak
day
piglet
develop
diarrhea
moreov
immun
group
show
decreas
number
diarrhea
piglet
fail
provid
complet
protect
howev
obviou
clinic
symptom
detect
immun
group
fig
clinic
assess
show
piglet
remain
activ
fleshi
prior
inocul
normal
fecal
consist
dpi
two
pb
treat
piglet
display
mild
lethargi
anorexia
start
dpi
next
day
half
pig
pb
treatment
group
third
treatment
group
develop
wateri
fece
lethargi
anorexia
progress
wateri
diarrhea
sever
dpi
gradual
declin
thereaft
howev
treatment
group
show
clinic
symptom
diarrhea
entir
experi
tabl
summar
progress
clinic
sign
throughout
studi
pedvassoci
mortal
occur
studi
fecal
shed
pedv
detect
rectal
swab
test
piglet
prior
virul
pedv
inocul
piglet
pb
treat
group
test
posit
pedv
rna
dpi
maximum
mean
ct
valu
dpi
pedv
rna
detect
fecal
swab
sampl
four
piglet
immun
group
lower
piglet
pb
treat
group
howev
pedv
rna
sporad
detect
present
extrem
low
level
rna
level
treat
group
tabl
sacrif
piglet
small
intestin
sampl
pb
treatment
group
reveal
promin
chang
character
thinner
intestin
mucosa
increas
transpar
mucosa
swell
congest
microscop
examin
jejunum
diarrhea
piglet
pb
treatment
group
reveal
multifoc
diffus
villou
atrophi
swell
slough
attenu
villou
fusion
numer
villi
furthermor
patholog
chang
observ
examin
treatment
group
sampl
larg
amount
immunofluorescencestain
pedv
posit
cell
detect
jejunum
diarrhea
piglet
pb
treatment
group
pedv
antigen
mainli
observ
cytoplasm
villi
epitheli
cell
fig
coe
aa
sequenc
protein
c
phylogenet
analysi
perform
util
neighborjoin
method
bootstrap
replic
valu
determin
percentag
reliabl
intern
node
sequenc
strain
indic
red
circl
distribut
chart
glycosit
color
accord
potenti
score
nglyc
predict
result
green
red
blue
color
repres
potenti
potenti
juri
agreement
potenti
potenti
juri
agreement
respect
potenti
cross
default
threshold
repres
predict
glycosyl
site
long
occur
within
requir
sequon
asnxaaserthr
without
prolin
xaa
interpret
refer
color
figur
legend
reader
refer
web
version
articl
shown
fig
immatur
dc
either
semisuspend
suspend
round
appear
dendrit
process
fig
left
immatur
dc
stimul
lp
h
typic
express
dclike
morpholog
includ
significantli
larger
cell
bodi
irregular
shape
fig
right
flow
cytometri
analysi
reveal
uptak
dc
higher
compar
group
fig
assess
phenotyp
matur
marker
dc
via
flow
cytometri
express
remark
upregul
group
compar
control
fig
mix
leukocyt
reaction
use
determin
whether
abil
pedvtreat
dc
stimul
tcell
prolifer
influenc
vitro
studi
reveal
dc
stronger
abil
activ
tcell
dct
cell
ratio
fig
addit
result
show
dc
treat
signific
level
mrna
express
ifnc
compar
control
group
chang
could
detect
secret
fig
tabl
summari
clinic
sign
fecal
consist
per
group
day
postinocul
dpi
piglet
group
fecal
consist
pb
pb
normal
b
normal
normal
c
lethargi
anorexia
normal
anorexia
normal
normal
lethargi
anorexia
gaunt
normal
lethargi
anorexia
gaunt
normal
normal
lethargi
anorexia
gaunt
lethargi
anorexia
gaunt
normal
number
piglet
b
clinic
sign
c
fecal
score
isol
attenu
pandem
pedv
strain
urgent
issu
pedv
control
studi
success
isol
passag
vero
cell
viru
success
attenu
piglet
challeng
experi
data
shown
growth
characterist
includ
cytopath
effect
infecti
titer
growth
kinet
indic
isol
possess
typic
characterist
pedv
subsequ
evalu
immun
protect
potenti
attenu
strain
studi
elicit
stronger
specif
immun
product
neutral
antibodi
vaccin
moreov
isol
capabl
protect
piglet
diarrhea
sever
diseas
process
follow
viral
challeng
also
reveal
higher
immun
protect
effici
compar
vaccin
group
abil
promot
dc
function
cellular
matur
induc
lymphocyt
cell
prolifer
proinflammatori
cytokin
secret
antigen
present
necessari
assess
potenti
antigen
initi
innat
adapt
immun
respons
demonstr
strain
stronger
potent
induc
dc
matur
mrna
express
ifnc
dc
play
import
role
differenti
naiv
tcell
ifncproduc
cell
ifnc
help
direct
immun
respons
regul
immun
network
caus
antivir
effect
furthermor
treat
dc
also
exhibit
stronger
stimul
effect
lymphocyt
cell
final
worth
note
treatment
group
show
higher
viru
load
group
despit
ident
moi
illustr
viru
easier
identifi
captur
dc
protein
pedv
close
associ
receptor
bind
neutral
antibodi
induc
natur
host
phylogenet
analysi
isol
base
sgene
nucleotid
deduc
aa
indic
isol
cluster
sever
pedv
epidem
strain
recent
year
attenu
vaccin
isol
howev
neutral
epitop
protein
strain
highli
homolog
compar
select
isol
addit
worth
note
high
homolog
coe
epitop
prevail
strain
isol
sinc
pedv
pandem
cluster
one
independ
big
group
thu
reveal
good
candid
vaccin
import
posttransl
modif
pedv
spike
protein
main
featur
nlink
glycosyl
attach
high
mannos
core
amid
nitrogen
asparagin
context
conserv
asnxserthr
motif
via
comparison
analysi
netnglyc
predict
result
protein
compar
found
three
one
addit
glycosyl
site
may
form
protein
respect
result
reveal
glycan
abil
form
barrier
thu
shield
antigen
potenti
viru
neutral
epitop
influenc
identif
immun
respons
downstream
element
analyz
potenti
influenc
immunogen
protein
glycosyl
site
compar
spatial
posit
nglycosyl
site
via
homolog
model
method
howev
surpris
found
two
extra
aa
nglycosyl
site
complet
cover
sequenc
posit
protein
furthermor
site
protein
also
prove
partial
hidden
region
previou
studi
report
potenti
porcin
aminopeptidas
n
papn
bind
site
region
pedv
protein
report
pedv
use
porcin
apn
receptor
consequ
enabl
viru
enter
host
cell
recogn
immun
cell
initi
via
bind
protein
cellular
receptor
therefor
suggest
differ
immun
effici
could
partli
attribut
epitop
exposur
cell
bind
influenc
addit
glycosyl
site
moreov
highli
virul
virus
emerg
sinc
two
addit
glycosyl
site
like
acquir
select
pressur
thu
provid
complet
shield
region
may
associ
viral
escap
immun
system
howev
futur
studi
could
involv
gener
specif
mutant
use
revers
genet
valid
suggest
summari
studi
reveal
cell
attenu
pedv
viru
display
effect
immun
protect
piglet
could
attribut
strong
abil
stimul
dc
activ
tcell
prolifer
strain
promis
vaccin
candid
assist
develop
specif
direct
vaccin
protect
strategi
pedv
pig
farm
